Maxim Group analyst Jason McCarthy downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Hold.
MobileFuse Expands Partnership With LiveRamp, Increases Publisher Fill Rates Over 300%
Leading digital advertising platform, MobileFuse, and LiveRamp's Authenticated Traffic Solution help publishers improve privacy-centric monetization by 303%NEW YORK, April 30, 2024 /PRNewswire/ -- MobileFuse, one of
